Titan Medical (TSX:TMD) said today that it inked a deal with Longtai Medical to convert $2 million Longtai paid as a distributorship deposit to equity, making Longtai the robotic surgical company’s largest shareholder. The conversion comes 2 years after Titan Medical and Longtai negotiated a deal that would have made Longtai the company’s exclusive distributor of its…

Titan Medical (TSX:TMD) said today that it closed a stock offering worth about $7 million for the Sport robot-assisted surgery platform it’s developing. The round consisted of two tranches, according to Toronto-based Titan: an initial round worth $5.7 million (C$7.3 million) and a subsequent $1.3 million (C$1.7 million)  tranche, for gross proceeds of roughly $7.1 million…

Titan Medical (TSX:TMD) today announced the 2nd closing of a public offering of shares, bringing in an additional $1.3 million (CDN $1.7 million) on top of a previously raised $5.7 million (CDN $7.3 million) for a total of $7.1 million (CDN $8.9 million). The Toronto-based surgical robotics company said it sold an additional 11.1 million shares…

Titan Medical (TSX:TMD) said today it inked a collaborative deal with Florida Hospital Nicholson Center to engage in a feasibility and validation study of Titan’s Sport robotic surgical system as the company seeks regulatory approval for the platform. The Toronto-based robotic surgical system developer said it expects to commence the studies in the 4th quarter, with…

Titan Medical (TSX:TMD) said today that it raised nearly $6 million in a public offering, with company insiders putting up another $166,000. Toronto-based Titan, which is developing the Sport robot-assisted surgery platform, had said it might float up to 100 million shares, which would have fetched $11.5 million. In the event the company floated nearly 48.4 million shares…

Titan Medical (TSX:TMD) said today that it plans to float as many as 100 million shares in a public offering that could fetch as much as $11.5 million for the Sport robot-assisted surgery platform it’s developing. The Toronto-based company said it will offer at least 46.7 million shares at 11.5¢ (C15.0¢) apiece, for minimum gross proceeds of…

Titan Medical (CVE:TMD) said today its shareholders approved a reverse stock split. The ratio of shares has yet to be announced, according to a press release, and will be determined by the board of directors of the company in its sole discretion. Toronto-based Titan Medical added that the range of post-consolidation shares will be a single…

Titan Medical – the young, upstart Canadian robotic surgery company – is making a comeback this year. Just today, the company announced the completion of initial formative human factors studies for its Sport single port robotic surgical system. The Sport system boasts the ability for a variety of surgical instruments on snake-like arms to be deployed…

Titan Medical (CVE:TMD) said today that it’s spiking talks with Chinese distributor Longtai Medical over its Sport robot-assisted surgery platform so it can focus on winning regulatory approvals in the U.S. and Europe. Back in October 2015, Toronto-based Titan inked a private placement deal with Longtai, a subsidiary of Chinese medical device distributor Ningbo Long Hengtai International Trade…

Titan Medical (CVE:TMD) said today it closed a $5.6 million offering, with funds slated to support the continued development of its robotic Sport surgical platform. The Toronto-based company floated approximately 21.5 million units at 26¢ (CAD 35¢) per unit. Each unit in the offering consists of 1 share of the company and 2 half-shares of purchase warrants, 1 due…

Titan Medical (CVE:TMD) said last Friday it filed a shelf prospectus for its upcoming offering, looking to raise a maximum of $5.6 million to support its Sport robotic surgical system. Titan Medical said it will look to float between 15.3 million and 21.5 million units in the sale, with hoped for proceeds of between between $4…

Titan Medical (CVE:TMD) today priced an upcoming overnight equity offering, looking to raise $5.6 million. The Toronto-based robotic device developer is looking to offer units at 26¢ (CAD 35¢) per unit. Each unit in the offering will consist of 1 share of the company and 2 half-shares of purchase warrants, 1 due 2019 and 1 due…

Robotic surgery is taking off, and the field is becoming increasingly diverse. We’ve collected information on the biggest players in the field so far. Intuitive Surgical’s da Vinci robot remains the premier surgical robotics company, with other companies including Stryker and Zimmer-Biomet only getting into the field in recent years. Read on to find out more.…